HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events

被引:1207
作者
Barter, Philip
Gotto, Antonio M.
LaRosa, John C.
Maroni, Jaman
Szarek, Michael
Grundy, Scott M.
Kastelein, John J. P.
Bittner, Vera
Fruchart, Jean-Charles
机构
[1] Heart Res Inst, Sydney, NSW, Australia
[2] Cornell Univ, Joan & Sanford I Weill Med Coll, New York, NY USA
[3] SUNY Hlth Sci Ctr, Brooklyn, NY 11203 USA
[4] Pfizer, New York, NY USA
[5] Univ Texas, SW Med Ctr, Ctr Human Nutr, Dallas, TX 75235 USA
[6] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands
[7] Univ Alabama Birmingham, Div Cardiovasc Dis, Birmingham, AL 35294 USA
[8] Inst Pasteur, F-59019 Lille, France
关键词
D O I
10.1056/NEJMoa064278
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Background High-density lipoprotein (HDL) cholesterol levels are a strong inverse predictor of cardiovascular events. However, it is not clear whether this association is maintained at very low levels of low-density lipoprotein (LDL) cholesterol. Methods A post hoc analysis of the recently completed Treating to New Targets (TNT) study assessed the predictive value of HDL cholesterol levels in 9770 patients. The primary outcome measure was the time to a first major cardiovascular event, defined as death from coronary heart disease, nonfatal non-procedure-related myocardial infarction, resuscitation after cardiac arrest, or fatal or nonfatal stroke. The predictive relationship between HDL cholesterol levels at the third month of treatment with statins and the time to the first major cardiovascular event was assessed in univariate and multivariate analyses and was also assessed for specific LDL cholesterol strata, including subjects with LDL cholesterol levels below 70 mg per deciliter (1.8 mmol per liter). Results The HDL cholesterol level in patients receiving statins was predictive of major cardiovascular events across the TNT study cohort, both when HDL cholesterol was considered as a continuous variable and when subjects were stratified according to quintiles of HDL cholesterol level. When the analysis was stratified according to LDL cholesterol level in patients receiving statins, the relationship between HDL cholesterol level and major cardiovascular events was of borderline significance (P=0.05). Even among study subjects with LDL cholesterol levels below 70 mg per deciliter, those in the highest quintile of HDL cholesterol level were at less risk for major cardiovascular events than those in the lowest quintile (P=0.03). Conclusions In this post hoc analysis, HDL cholesterol levels were predictive of major cardiovascular events in patients treated with statins. This relationship was also observed among patients with LDL cholesterol levels below 70 mg per deciliter.
引用
收藏
页码:1301 / 1310
页数:10
相关论文
共 24 条
[1]
High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport [J].
Assmann, G ;
Schulte, H ;
vonEckardstein, A ;
Huang, YD .
ATHEROSCLEROSIS, 1996, 124 :S11-S20
[2]
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins [J].
Baigent, C ;
Keech, A ;
Kearney, PM ;
Blackwell, L ;
Buck, G ;
Pollicino, C ;
Kirby, A ;
Sourjina, T ;
Peto, R ;
Collins, R ;
Simes, J .
LANCET, 2005, 366 (9493) :1267-1278
[3]
A prospective study of HDL-C and cholesteryl ester transfer protein gene mutations and the risk of coronary heart disease in the elderly [J].
Curb, JD ;
Abbott, RD ;
Rodriguez, BL ;
Masaki, K ;
Chen, R ;
Sharp, DS ;
Tall, AR .
JOURNAL OF LIPID RESEARCH, 2004, 45 (05) :948-953
[4]
Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels - Results of AFCAPS/TexCAPS [J].
Downs, JR ;
Clearfield, M ;
Weis, S ;
Whitney, E ;
Shapiro, DR ;
Beere, PA ;
Langendorfer, A ;
Stein, EA ;
Kruyer, W ;
Gotto, AM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (20) :1615-1622
[5]
Serum lipids and incidence of coronary heart disease - Findings from the systolic hypertension in the elderly program (SHEP) [J].
Frost, PH ;
Davis, BR ;
Burlando, AJ ;
Curb, JD ;
Guthrie, GP ;
Isaacsohn, JL ;
WassertheilSmoller, S ;
Wilson, AC ;
Stamler, J .
CIRCULATION, 1996, 94 (10) :2381-2388
[6]
Gillespie MJ, 2006, CIRCULATION, V113, pE805
[7]
HIGH-DENSITY LIPOPROTEIN CHOLESTEROL AND CARDIOVASCULAR-DISEASE - 4 PROSPECTIVE AMERICAN-STUDIES [J].
GORDON, DJ ;
PROBSTFIELD, JL ;
GARRISON, RJ ;
NEATON, JD ;
CASTELLI, WP ;
KNOKE, JD ;
JACOBS, DR ;
BANGDIWALA, S ;
TYROLER, HA .
CIRCULATION, 1989, 79 (01) :8-15
[8]
HIGH-DENSITY LIPOPROTEIN AS A PROTECTIVE FACTOR AGAINST CORONARY HEART-DISEASE - FRAMINGHAM STUDY [J].
GORDON, T ;
CASTELLI, WP ;
HJORTLAND, MC ;
KANNEL, WB ;
DAWBER, TR .
AMERICAN JOURNAL OF MEDICINE, 1977, 62 (05) :707-714
[9]
Grundy Scott M, 2004, J Am Coll Cardiol, V44, P720, DOI 10.1016/j.jacc.2004.07.001
[10]
Triglycerides and HDL-cholesterol as risk factors for ischemic heart disease. Results from the Quebec cardiovascular study [J].
Lamarche, B ;
Despres, JP ;
Moorjani, S ;
Cantin, B ;
Dagenais, GR ;
Lupien, PJ .
ATHEROSCLEROSIS, 1996, 119 (02) :235-245